Corey C. Foster

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Tanguy Y. Seiwert, Corey C. Foster, Elizabeth A. Blair et al. · Annals of Oncology · 2018 · 233 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Corey C. Foster, Marcus Couey, Sara Kochanny et al. · Cancer · 2021 · 81 citations · Full text

Medicine, Immunology, Oncology +17

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

Corey C. Foster, J.M. Melotek, Ryan J. Brisson et al. · Oral Oncology · 2018 · 55 citations

Medicine, Oncology, Radiation Oncology +7

Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy

Will Jackson, Daniel A. Hamstra, Skyler B. Johnson et al. · Cancer · 2013 · 54 citations · Full text

Medicine, Surgery, Urology +17

Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis

Corey C. Foster, David J. Sher, Chad G. Rusthoven et al. · Radiation Oncology · 2019 · 54 citations · Full text

Medicine, Oncology, Radiation Oncology +16